Quantitative susceptibility mapping (QSM) studies have demonstrated that patients with T2DM and cognitive impairment exhibit heightened iron deposition in specific brain regions, including the right caudate nucleus, substantia nigra, and left putamen, compared to their cognitively intact counterparts
By combining peptides with complementary mechanisms, AnagenX is formulated to create a layered effect that amplifies their impact
In tirzepatide, dual agonism of GIP and GLP-1 receptors may amplify these effects via: Enhanced insulinotropic action Greater suppression of appetite Synergistic modulation of fat metabolism This is an area of active research and an example of rational drug design rooted in receptor biology
Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR, Pretorius E
2025 Jul 22